J Med Microbiol 57 (2008), 384-387; DOI: 10.1099/jmm.0.47556-0
© 2008 Society for General Microbiology
ISSN 1473-5644
Legionnaires' disease in immunocompromised patients: a case report of Legionella longbeachae pneumonia and review of the literature
Philipp Kümpers1,
Andreas Tiede1,
Philip Kirschner2,
Jutta Girke1,
Arnold Ganser1 and
Dietrich Peest1
1 Department of Internal Medicine, Hannover Medical School, Hannover, Germany
2 Department of Medical Microbiology, Hannover Medical School, Hannover, Germany
Correspondence
Philipp Kümpers
kuempers.philipp{at}mh-hannover.de
Received 3 August 2007
Accepted 24 October 2007
In addition to Legionella pneumophila, about 20 Legionella species have been documented as human pathogens. The majority of infections by non-pneumophila Legionella species occur in immunocompromised and splenectomized patients. Here, we report a case of ‘classical’ lobar pneumonia caused by Legionella longbeachae in a splenectomized patient receiving corticosteroids for chronic immune thrombocytopenia. Tests for Legionella antigen were negative. L. longbeachae was immediately detected in bronchoalveolar fluid by PCR and subsequently confirmed by culture on legionella-selective media. The features of Legionnaires' disease in immunocompromised patients with special emphasis on significance and detection of non-pneumophila species are reviewed.
Abbreviations: BAL, bronchoalveolar lavage.
 |
Introduction
|
|---|
Legionella is consistently reported among the most commonly identified pathogens in community- and hospital-acquired pneumonia (Stout & Yu, 1997). About 20 different pathogenic species have been reported, with Legionella pneumophila accounting for more than 80 % of human infections. The most commonly isolated non-pneumophila Legionella spp. are Legionella longbeachae (3.2 %), Legionella bozemanae (2.4 %), Legionella micdadei, Legionella dumoffii and Legionella feeleii (2.2 % combined) (Yu et al., 2002). L. longbeachae is far more common in Australia (30.4 %), where infection has been associated with exposure to potting mixes (Yu et al., 2002; O'Connor et al., 2007).
Legionnaires' disease can be acquired by the inhalation of contaminated aerosols or by microaspiration of contaminated water (Stout & Yu, 1997). Domestic aquatic reservoirs have been described as a source both in nosocomial and community-acquired infections (Pedro-Botet et al., 2002).
The clinical features of pneumonia caused by Legionella spp. are diverse. Early symptoms include fever, malaise, myalgia, anorexia and headache. Cough is only slightly productive. During the course of illness, fever exceeding 40 °C, stupor, and respiratory and even multiorgan failure may develop. Elevation of creatinine kinase and diarrhoea have been reported as disease-specific symptoms for legionellosis in a comparative study (Sopena et al., 1998).
The incidence of community-acquired pneumonia caused by Legionella is probably underestimated as many species and serogroups are not properly detected by commercially available tests (Roig & Rello, 2003). This issue is of importance as patients with community-acquired legionellosis are more likely to require admission to the hospital and the intensive care unit compared to patients with pneumonia of other causes (Sopena et al., 1998).
Legionnaires' disease has been historically referred to as ‘atypical’ pneumonia, based on its clinical presentation and the notion that chest radiographic findings are neither lobar nor consolidating, as seen in the ‘classical’ pyogenic pneumonia (Tan et al., 2000). We report the case of a patient with unilateral lobar cavitating pneumonia in which L. longbeachae was the only aetiological agent. In addition, we summarize the special features of Legionnaires' disease in immunocompromised patients.
|
Case report
|
|---|
A 69-year-old man presented to the emergency room in October 2006 with complaints of dyspnoea on effort, somnolence, a non-productive cough, fever and night sweats. History was significant for chronic idiopathic thrombocytopenic purpura for which he underwent splenectomy in 2002 and relapsed thereafter. Three weeks prior to admission, he experienced fatigue and a new episode of severe thrombocytopenia, for which he had received dexamethasone at a dose of 40 mg per day for 3 days.
On admission, his temperature was 39.4 °C, heart rate was 117 beats min–1, blood pressure was 115/72 mmHg and respiratory rate was 26 min–1. Physical examination revealed fine crackles and marked dullness of the right middle lobe. Petechiae and multiple ecchymoses were present on the lower extremities, trunk and oral mucosa.
Laboratory testing was remarkable for leukocytosis (13.4 nl–1), thrombocytopenia (3 nl–1) and elevated C-reactive protein (CRP, 392 mg l–1, normal <5 mg l–1). Hepatic, pancreatic and renal parameters as well as urinalysis were normal. Capillary blood gas analysis confirmed moderate hypoxia and respiratory alkalosis due to hyperventilation (pO2 66 mmHg, pCO2 26 mmHg, pH 7.51, HCO3 21.1 mmol l–1).
Chest radiograph and computed tomography revealed a distinct confluent infiltration of the right middle lobe including two small cavitations. Pleural effusions were absent. Bronchial obstruction or external compression could be excluded (Fig. 1
).
View larger version (60K):
[in this window]
[in a new window]
|
Fig. 1. (a, b) Chest radiograph on admission showing airspace consolidation of the right middle lobe. (c) Chest-CT additionally revealed two small cavitations ( 10x10 mm, black arrows) and excluded bronchial obstruction or external compression. Pleural effusions were absent.
|
|
|
Microbiology
|
|---|
Gram and acid-fast stains of bronchoalveolar lavage (BAL) fluid were negative. A Legionella-genus specific PCR detected L. longbeachae DNA in the BAL fluid within 18 h [nucleic acids extracted from an equivalent of 25 µl BAL fluid (QIAamp DNA Mini kit; Qiagen) were used in a PCR (40 cycles with primers U24 (5'-CGC CTT CGC CAC TGG TGT TGT T-3') and L65 (5'-AAC GCG TAG GAA TAT GCC TT AGA-3'))]. Identification was enabled by sequence determination of the amplified 16S rDNA fragment (capillary electrophoresis GeneticAnalyser; Applied Biosystems).
Colonies typical for Legionella grew on a Legionella medium (Legionella-BCYE; Becton Dickinson) after several days of incubation, and were identified as L. longbeachae by partial sequencing of the 16S rRNA gene (Bottger, 1989). Legionella urine antigen enzyme immunoassay (Biotest) tested negative. Cultures for other bacteria (including mycobacteria), fungi and respiratory viruses were negative. All blood cultures remained negative. On the basis of these results, we made a definitive diagnosis of L. longbeachae pneumonia.
|
Management and clinical course
|
|---|
During initial antibiotic therapy with intravenous piperacillin/tazobactam for 24 h, the clinical symptoms worsened markedly. Identification of L. longbeachae in BAL fluid prompted a change of antibiotic therapy to intravenous moxifloxacin. The patient recovered quickly and was switched to oral moxifloxacin for a total of 12 days. Thrombocytopenia markedly improved as the patient recovered.
|
Discussion
|
|---|
In the case reported here, a clinical presentation with high fever, markedly elevated CRP and the radiographic presentation of cavitating pneumonia in a splenectomized patient was suggestive of classical pneumonia caused by Streptococcus pneumoniae. In contrast, Legionnaires' disease has been historically referred to as ‘atypical’ pneumonia based on its clinical presentation and the long-held belief that chest radiographic findings are neither lobar nor consolidating (Tan et al., 2000). Three-quarters of patients with L. pneumophila pneumonia present with an abnormal chest X-ray. Patchy pneumonic infiltrates, predominantly of the lower lobes, but also circumscribed or even lobar consolidations are observed. Cavitations are rather uncommon (Tan et al., 2000). No study has addressed the radiographic manifestations of legionellosis in the immunocompromised host, but cavitations are probably more common than in immunocompetent patients (Di Stefano et al., 2007; Muder et al., 1987; Tan et al., 2000; Fraser et al., 2004; Dowling et al., 1983; Senecal et al., 1987). In conclusion, Legionella spp., like other causes of ‘atypical’ pneumonia, cannot be confirmed or excluded by distinct radiographic patterns.
Clinical practice guidelines recommend testing for Legionella in selected patients, including seriously ill patients without an alternative diagnosis, older and immunocompromised patients, as well as patients nonresponsive to beta-lactam antibiotics (British Thoracic Society Standards of Care Committee, 2001; Mandell et al., 2007). Legionella spp. do not grow on standard microbiology media, and are usually not detected by blood culture or Gram stain or culture of sputum. Culture isolation from BAL fluid is considered the gold standard of diagnosis, but may not always be helpful for the clinician because it takes 4–10 days. Moreover, currently available selective media are probably suboptimal for the isolation of non-pneumophila Legionella spp. (Muder & Yu, 2002). The availability of tests for Legionella antigen in the urine resulted in a decreasing use of cultures and serological studies (Benin et al., 2002). The major drawback is that urinary antigen tests are virtually limited to L. pneumophila (Roig & Rello, 2003). Due to the shortcomings of culture and urinary antigen tests, PCR appears to be a promising tool for the simultaneous, rapid and reliable detection of many different Legionella species. Most of the commercially available assays target species-specific regions within the 16S and 5S rRNA genes and in the macrophage inhibitor potentiator (mip) gene. PCR techniques using ribosomal genes as target have the potential to provide a rapid diagnosis of several Legionella spp. with the use of readily obtainable respiratory tract specimens (Bencini et al., 2007; Diederen et al., 2006).
Numerous case reports suggest a higher rate of non-pneumophila Legionella spp. among immunocompromised and splenectomized patients than in immunocompetent hosts (Jaeger et al., 1988; Jernigan et al., 1994; Korman et al., 1998; McClelland et al., 2004; Schwebke et al., 1990; Wilkinson et al., 1987; Fang et al., 1990; Garcia et al., 2004; Lang et al., 1990; Radaelli et al., 1991; Singh et al., 2002). L. longbeachae was first described as a cause of pneumonia in two Californian patients (McKinney et al., 1981). Since then, only nine cases have been reported outside Australia. Interestingly, three of those patients were splenectomized (Gorelik et al., 2004; Lang et al., 1990), and three others received immunosuppressive drugs because of systemic lupus erythematodes (Garcia et al., 2004; McClelland et al., 2004) or heart transplantation (Korman et al., 1998).
The primary host defence mechanism against Legionella is cell-mediated immunity, similar to other intracellular pathogens. Depression of cell-mediated immunity by glucocorticoids and immunosuppressive drugs may predispose the host to Legionnaires' disease (Schlossberg & Bonoan, 1998). Transplant recipients carry the highest risk (Singh et al., 2002). Corticosteroids and disorders associated with immunosuppression, e.g. cancer, are independent risk factors (Poupard et al., 2007). Hairy cell leukaemia also increases the risk of Legionella infection because of monocyte deficiency and dysfunction (Fang et al., 1990; Radaelli et al., 1991). In contrast, the incidence of Legionnaires' disease is not higher in neutropenia, acute leukaemia and HIV infection (Schlossberg & Bonoan, 1998).
Loss of the spleen due to splenectomy, spleen irradiation, infarction or sickle cell disease increases the risk of infection with S. pneumoniae, Streptococcus meningitidis and Haemophilus influenzae. An increased risk of legionellosis has not been recognized. However, there is a striking coincidence of splenectomy and infections with non-pneumophila Legionella spp., as reported here and in previous reports by Gorelik et al. (2004) and Lang et al. (1990). The spleen, by delivery of antigen, regulation of lymphocyte traffic, opsonization, phagocytosis and as a site of lymphocyte priming, plays an important role during any bacterial infection. Accumulating reports of infection with non-pneumophila spp. in splenectomized patients suggest that spleen-related factors might be especially important in the defence against these species.
Different Legionella species must be considered as causal agents of pneumonia in immunocompromised hosts, even if radiographic appearance suggests pneumococcal pneumonia. Antigen assays and serology can fail to detect non-pneumophila Legionella species. PCR testing of BAL fluid should be considered in high-risk patients.
|
REFERENCES
|
|---|
Bencini, M. A., van den Brule, A. J., Claas, E. C., Hermans, M. H., Melchers, W. J., Noordhoek, G. T., Salimans, M. M., Schirm, J., Vink, C. & other authors (2007). A multicenter comparison of molecular methods for the detection of Legionella in sputum samples. J Clin Microbiol 45, 3390–3392.[Abstract/Free Full Text]
Benin, A. L., Benson, R. F. & Besser, R. E. (2002). Trends in legionnaires disease, 1980–1998: declining mortality and new patterns of diagnosis. Clin Infect Dis 35, 1039–1046.[CrossRef][Medline]
Bottger, E. C. (1989). Rapid determination of bacterial ribosomal RNA sequences by direct sequencing of enzymatically amplified DNA. FEMS Microbiol Lett 53, 171–176.[Medline]
British Thoracic Society Standards of Care Committee (2001). BTS guidelines for the management of community acquired pneumonia in adults. Thorax 56 (Suppl. 4), IV1–IV64.[Medline]
Diederen, B. M., de Jong, C. M., Kluytmans, J. A., van der Zee, A. & Peeters, M. F. (2006). Detection and quantification of Legionella pneumophila DNA in serum: case reports and review of the literature. J Med Microbiol 55, 639–642.[Abstract/Free Full Text]
Di Stefano, F., Verna, N. & Di Gioacchino, M. (2007). Cavitary Legionella pneumonia in a patient with immunodeficiency due to Hyper-IgE syndrome. J Infect 54, e121–e123.[CrossRef][Medline]
Dowling, J. N., Kroboth, F. J., Karpf, M., Yee, R. B. & Pasculle, A. W. (1983). Pneumonia and multiple lung abscesses caused by dual infection with Legionella micdadei and Legionella pneumophila. Am Rev Respir Dis 127, 121–125.[Medline]
Fang, G. D., Stout, J. E., Yu, V. L., Goetz, A., Rihs, J. D. & Vickers, R. M. (1990). Community-acquired pneumonia caused by Legionella dumoffii in a patient with hairy cell leukemia. Infection 18, 383–385.[CrossRef][Medline]
Fraser, T. G., Zembower, T. R., Lynch, P., Fryer, J., Salvalaggio, P. R., Yeldandi, A. V. & Stosor, V. (2004). Cavitary Legionella pneumonia in a liver transplant recipient. Transpl Infect Dis 6, 77–80.[CrossRef][Medline]
Garcia, C., Ugalde, E., Campo, A. B., Minambres, E. & Kovacs, N. (2004). Fatal case of community-acquired pneumonia caused by Legionella longbeachae in a patient with systemic lupus erythematosus. Eur J Clin Microbiol Infect Dis 23, 116–118.[CrossRef][Medline]
Gorelik, O., Lazarovich, Z., Boldur, I., Almoznino-Sarafian, D., Alon, I., Modai, D. & Cohen, N. (2004). Legionella in two splenectomized patients. Coincidence or causal relationship? Infection 32, 179–181.[CrossRef][Medline]
Jaeger, T. M., Atkinson, P. P., Adams, B. A., Wright, A. J. & Hurt, R. D. (1988). Legionella bozemanii pneumonia in an immunocompromised patient. Mayo Clin Proc 63, 72–76.[Medline]
Jernigan, D. B., Sanders, L. I., Waites, K. B., Brookings, E. S., Benson, R. F. & Pappas, P. G. (1994). Pulmonary infection due to Legionella cincinnatiensis in renal transplant recipients: two cases and implications for laboratory diagnosis. Clin Infect Dis 18, 385–389.[Medline]
Korman, T. M., Fuller, A., Ibrahim, J., Kaye, D. & Bergin, P. (1998). Fatal Legionella longbeachae infection following heart transplantation. Eur J Clin Microbiol Infect Dis 17, 53–55.[CrossRef][Medline]
Lang, R., Wiler, Z., Manor, J., Kazak, R. & Boldur, I. (1990). Legionella longbeachae pneumonia in a patient splenectomized for hairy-cell leukemia. Infection 18, 31–32.[CrossRef][Medline]
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Jr, Musher, D. M. & other authors (2007). Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 (Suppl. 2), S27–S72.[CrossRef][Medline]
McClelland, M. R., Vaszar, L. T. & Kagawa, F. T. (2004). Pneumonia and osteomyelitis due to Legionella longbeachae in a woman with systemic lupus erythematosus. Clin Infect Dis 38, e102–e106.[CrossRef][Medline]
McKinney, R. M., Porschen, R. K., Edelstein, P. H., Bissett, M. L., Harris, P. P., Bondell, S. P., Steigerwalt, A. G., Weaver, R. E., Ein, M. E. & other authors (1981). Legionella longbeachae species nova, another etiologic agent of human pneumonia. Ann Intern Med 94, 739–743.[Abstract/Free Full Text]
Muder, R. R. & Yu, V. L. (2002). Infection due to Legionella species other than L. pneumophila. Clin Infect Dis 35, 990–998.[CrossRef][Medline]
Muder, R. R., Yu, V. L. & Parry, M. F. (1987). The radiologic manifestations of Legionella pneumonia. Semin Respir Infect 2, 242–254.[Medline]
O'Connor, B. A., Carman, J., Eckert, K., Tucker, G., Givney, R. & Cameron, S. (2007). Does using potting mix make you sick? Results from a Legionella longbeachae case-control study in South Australia. Epidemiol Infect 135, 34–39.[CrossRef][Medline]
Pedro-Botet, M. L., Stout, J. E. & Yu, V. L. (2002). Legionnaires' disease contracted from patient homes: the coming of the third plague? Eur J Clin Microbiol Infect Dis 21, 699–705.[CrossRef][Medline]
Poupard, M., Campese, C., Bernillon, P. & Che, D. (2007). Factors associated with mortality in Legionnaires' disease, France, 2002–2004. Med Mal Infect 37, 325–330.[Medline]
Radaelli, F., Langer, M., Chiorboli, O., Proietti, D. & Baldini, L. (1991). Severe Legionella pneumophila infection in a patient with hairy cell leukemia in partial remission after alpha interferon treatment. Hematol Oncol 9, 125–128.[CrossRef][Medline]
Roig, J. & Rello, J. (2003). Legionnaires' disease: a rational approach to therapy. J Antimicrob Chemother 51, 1119–1129.[Abstract/Free Full Text]
Schlossberg, D. & Bonoan, J. (1998). Legionella and immunosuppression. Semin Respir Infect 13, 128–131.[Medline]
Schwebke, J. R., Hackman, R. & Bowden, R. (1990). Pneumonia due to Legionella micdadei in bone marrow transplant recipients. Rev Infect Dis 12, 824–828.[Medline]
Senecal, J. L., St Antoine, P. & Beliveau, C. (1987). Legionella pneumophila lung abscess in a patient with systemic lupus erythematosus. Am J Med Sci 293, 309–314.[Medline]
Singh, N., Stout, J. E. & Yu, V. L. (2002). Legionnaires's disease in a transplant recipient acquired from the patient's home: implications for management. Transplantation 74, 755–756.[CrossRef][Medline]
Sopena, N., Sabria-Leal, M., Pedro-Botet, M. L., Padilla, E., Dominguez, J., Morera, J. & Tudela, P. (1998). Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest 113, 1195–1200.[CrossRef][Medline]
Stout, J. E. & Yu, V. L. (1997). Legionellosis. N Engl J Med 337, 682–687.[Free Full Text]
Tan, M. J., Tan, J. S., Hamor, R. H., File, T. M., Jr & Breiman, R. F. (2000). The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group. Chest 117, 398–403.[CrossRef][Medline]
Wilkinson, H. W., Thacker, W. L., Benson, R. F., Polt, S. S., Brookings, E., Mayberry, W. R., Brenner, D. J., Gilley, R. G. & Kirklin, J. K. (1987). Legionella birminghamensis sp. nov. isolated from a cardiac transplant recipient. J Clin Microbiol 25, 2120–2122.[Abstract/Free Full Text]
Yu, V. L., Plouffe, J. F., Pastoris, M. C., Stout, J. E., Schousboe, M., Widmer, A., Summersgill, J., File, T., Heath, C. M. & other authors (2002). Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis 186, 127–128.[CrossRef][Medline]
This article has been cited by other articles:
|
|
|
|
 
I. Gobin, M. Susa, G. Begic, E. L. Hartland, and M. Doric
Experimental Legionella longbeachae infection in intratracheally inoculated mice
J. Med. Microbiol.,
June 1, 2009;
58(6):
723 - 730.
[Abstract]
[Full Text]
[PDF]
|
|
|
TOP
Introduction
Case report
